A Longitudinal Study Evaluating the Impact of 0.01% Atropine in High Myopic Children (RAMCOM-II Study)
Purpose: To assess the safety and efficacy of the 4-year administration of 0.01% atropine following a 1-year observation period in high myopic children. Methods: The RAMCOM-II study continues the RAMCOM study, designed as an interventional nonrandomized study. Participants were observed for 1 year w...
Saved in:
| Main Authors: | Pradeep Agarwal, Veenu Maan, Ashi Khurana, Samir Sutar, Lokesh Chauhan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-07-01
|
| Series: | Journal of Current Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/joco.joco_107_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Repeated Low-Level Red Light Versus 0.01% Atropine Treatment on Axial Length and Choroidal Parameters in Children with Myopia
by: Xuena Pang, et al.
Published: (2025-06-01) -
0.01% atropine combined with carteolol hydrochloride can inhibit the scleral remodeling in guinea pigs with form-deprivation myopia
by: Qin Xiang, et al.
Published: (2025-08-01) -
Morning Administration is More Effective than Evening Administration of 0.01% Atropine Eye Drops Combined with Orthokeratology for Myopia Control
by: Shuting Xiong, et al.
Published: (2025-08-01) -
Atropine in Myopia
by: Priyanka Mishra, et al.
Published: (2021-07-01) -
A systematic review with meta-analysis on the efficacy of 0.01% atropine eyedrops in preventing myopia progression in worldwide children’s populations
by: Pierluigi Navarra, et al.
Published: (2025-05-01)